Journal of Affective Disorders
Volume 68, Issue 2 , Pages 167-181 , April 2002

Mortality of patients with mood disorders: follow-up over 34–38 years

  • F Angst

      Affiliations

    • Institute of Social and Preventive Medicine, Zurich University, Zurich, Switzerland
    • ,
  • H.H Stassen

      Affiliations

    • Zurich University Psychiatric Hospital, Lenggstrasse 31 Mail Box 68, 8029 Zurich, Switzerland
    • ,
  • P.J Clayton

      Affiliations

    • Santa Fé, NM, USA
    • ,
  • J Angst

      Affiliations

    • Zurich University Psychiatric Hospital, Lenggstrasse 31 Mail Box 68, 8029 Zurich, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41-1-384-2611; fax: +41-1-384-2446

Received 29 February 2000 ,Accepted 3 April 2001.

References 

  1. Ahrens B, Müller-Oerlinghausen B, Schou M, Wolf T, Alda M, Grof E, et al. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J. Affect. Disord. 1995;33:67–75
  2. Akiskal HS, Bourgeois ML, Angst J, Post R, Möller H-J, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J. Affect. Disord. 2000;59:5–30
  3. Angst, F., 1992. Suizide im Vergleich zu anderen Todesursachen bei psychiatrischen Patienten. Katamnese von 1408 hospitalisierten Patienten über 18–32 Jahre. University of Zurich, Zurich.
  4. Angst, F., 1998. Mortalität und Prophylaxe bei Patienten mit affektiven Störungen nach 34–38 Jahren Follow-up. University of Zurich, Zurich.
  5. Angst, J., 1986. Verlauf und Ausgang affektiver und schizo-affektiver Ekrankungen. In: Huber, G. (Ed.), Zyklothymie – offene Fragen. 2. Hans Jörg Weitbrecht-Symposion, Bonn 22, Juni 1985. Tropon Arzneimittel, Köln, pp. 75–87.
  6. Angst J. Consensus discussion. J. Clin. Psychiatry. 1999;60:113–116
  7. Angst J, Battegay R, Poeldinger W. Zur Methodik der statistischen Bearbeitung des Therapieverlaufs depressiver Krankheitsbilder. Meth. Inform. Med. 1964;3:54–56
  8. Angst J, Preisig M. Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweiz Arch. Neurol. Psychiatr. 1995;146:5–16
  9. Angst J, Sellaro R, Angst F. Long-term outcome and mortality of treated versus untreated bipolar and depressed patients: a preliminary report. Int. J. Psychiatry Clin. Pract. 1998;2:115–119
  10. Angst J, Stassen HH. Verlaufsaspekte affektiver Psychosen: Suizide, Rückfallrisiko im Alter. In:  Huber G editors. Fortschritte in der Psychosenforschung? 7. Weissenauer Schizophrenie-Symposion, Bonn 1986. Stuttgart, New York: Schattauer; 1987;p. 145–164
  11. Angst J, Stassen HH, Gross G, Huber G, Stone MH. Suicide in affective and schizoaffective disorders. In:  Marneros A,  Tsuang MT editor. Affective and Schizoaffective Disorders. Berlin, Heidelberg, New York: Springer; 1990;p. 168–185
  12. Arato M, Demeter E, Rihmer Z, Somogyl E. Retrospective psychiatric assessment of 200 suicides in Budapest. Acta Psychiatr. Scand. 1988;77:454–456
  13. Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J. Clin. Psychiatry. 1999;60:77–84
  14. Baldwin JA. Schizophrenia and physical disease: A preliminary analysis of the data from the Oxford Record Linkage Study. In:  Hemmings G editors. Biochemistry of Schizophrenia and Addiction. In Search of a Common Factor. Lancaster: MTP Press; 1980;p. 297–318
  15. Barraclough B, Bunch J, Nelson B, Sainsbury P. A hundred cases of suicide: Clinical aspects. Br. J. Psychiatry. 1974;125:355–373
  16. Berglund M, Nilsson K. Mortality in severe depression. A prospective study including 103 suicides. Acta Psychiatr. Scand. 1987;76:372–380
  17. Black DW. Iowa record-linkage study: death rates in psychiatric patients. J. Affect. Disord. 1998;50:277–282
  18. Black DW, Winokur G, Mohandoss E, Woolson RF, Nasrallah A. Does treatment influence mortality in depressives? A follow-up of 1076 patients with major affective disorders. Ann. Clin. Psychiatry. 1989;1:165–173
  19. Black DW, Winokur G, Nasrallah A. Suicide in subtypes of major affective disorder. A comparison with general population suicide mortality. Arch. Gen. Psychiatry. 1987;44:878–880
  20. Blair-West GW, Cantor CH, Mellsop GW, Eyeson-Annan ML. Lifetime suicide risk in major depression; sex and age determinants. J. Affect. Disord. 1999;55:171–178
  21. Blair-West GW, Mellsop GW, Eyeson-Annan ML. Down-rating lifetime suicide risk in major depression. Acta Psychiatr. Scand. 1997;95:259–263
  22. Brent DA, Perper J, Moritz G, Allmam C, Friend A, Roth C, et al. Psychiatric risk factors for adolescent suicide: a case-control study. J. Am. Acad. Child Adolesc. Psychiatry. 1993;32:521–529
  23. Brodersen A, Licht RW, Vestergaard P, Olesen AV, Mortensen PB. Sixteen-year mortality in patients with affective disorder commenced on lithium. Br. J. Psychiatr. 2000;176:429–433
  24. Ciompi L, Medvecka J. Etude comparative de la mortalité a long terme dans les maladies mentales. Schweiz Arch. Neurol. Neurochir. Psychiatr. 1976;118:111–135
  25. Clayton PJ. Epidemiologic and risk factors in suicide. In:  Grinspoon L editors. Psychiatry Update. Washington, DC: American Psychiatric Press; 1983;p. 428–434
  26. Coppen A. Depression as a lethal disease: prevention strategies. J. Clin. Psychiatry. 1994;55:37–45
  27. Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C. Does lithium reduce the mortality of recurrent mood disorders?. J. Affect. Disord. 1991;23:1–7
  28. Dilsaver SC, Chen YW, Swann AC, Shoaib AM, Krajewski KJ. Suicidality in patients with pure and depressive mania. Am. J. Psychiatry. 1994;151:1312–1315
  29. Dorpat TL, Ripley HS. A study of suicide in the Seattle area. Compr. Psychiatry. 1960;1:349–359
  30. Dunner DL, Fleiss JL, Fieve RR. The course of development of mania in patients with recurrent depression. Am. J. Psychiatry. 1976;133:905–908
  31. Eastwood MR, Stiasny S, Meier HM, Woogh CM. Mental illness and mortality. Compr. Psychiatry. 1982;23:377–385
  32. Fawcett J, Scheftner W, Hedeker DD, Gibbons R, Coryell W. Clinical predictors of suicide in patients with major affective disorders: A controlled prospective study. Am. J. Psychiatry. 1987;144:35–40
  33. Felber W, Kyber A. Suizide und Parasuizide während und ausserhalb einer Lithiumprophylaxe. In:  Müller-Oerlinghausen B,  Berghöfer A editor. Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Stuttgart: Thieme; 1994;p. 53–59
  34. Fredman L, Schoenbach VJ, Kaplan BH, Blazer DG, James SA, Kleinbaum DG, et al. The association between depressive symptoms and mortality among older participants in the Epidemiologic Catchment Area–Piedmont Health Survey. J. Gerontol. 1989;44:S149–S156
  35. Goldstein RW, Black DW, Nasrallah A, Winokur G. The predictin of suicide: sensitivity, specificity, and predictive value of a multivariate model applied to suicide among 1906 patients with affective disorders. Arch. Gen. Psychiatry. 1991;48:418–422
  36. Guze SB, Robins E. Suicide and primary affective disorder. Br. J. Psychiatry. 1970;117:437–438
  37. Hagnell O, Lanke J, Rorsman B. Suicide and depression in the male part of the Lundby Study. Changes over time during a 25-year observation period. Neuropsychobiology. 1982;8:182–187
  38. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br. J. Psychiatry. 1997;170:205–228
  39. Henriksson MM, Aro HM, Marttunen MJ, Heikkinen ME, Isometsä ET, Kuoppasalmi KI, et al. Mental disorders and comorbidity in suicide. Am. J. Psychiatry. 1993;150:935–940
  40. Hoyer EH, Mortensen PB, Olesen AV. Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993. Br. J. Psychiatry. 2000;176:76–82
  41. Isaacson G, Bergman U, Rich CL. Epidemiological data suggest antidepressants reduce suicide risk among depressives. J. Affect. Disord. 1996;41:1–8
  42. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J. Am. Stat. Ass. 1958;53:457–481
  43. Kiloh LG, Andrews G, Neilson M. The long-term outcome of depressive illness. Br. J. Psychiatry. 1988;153:752–757
  44. Lee AS, Murray RM. The long-term outcome of Maudsley depressives. Br. J. Psychiatry. 1988;153:741–751
  45. Lindell FDK. Simple exact analysis of the standardised mortality ratio. J. Epidemiol. Community Health. 1984;38:85–88
  46. Martin RL, Cloninger CR, Guze SB, Clayton PJ. Mortality in a follow-up of 500 psychiatric outpatients. I. total mortality. Arch. Gen. Psychiatry. 1985;42:47–54
  47. Martin RL, Cloninger CR, Guze SB, Clayton PJ. Mortality in a follow-up of 500 psychiatric outpatients. II. Cause-specific mortality. Arch. Gen. Psychiatry. 1985;42:58–66
  48. Marttunen MJ, Aro HM, Henriksson MM, Lönnqvist JK. Mental disorders in adolescent suicide. DSM-III-R Axes I and II diagnoses in suicides among 13- to 19-year-olds in Finland. Arch. Gen. Psychiatry. 1991;48:834–839
  49. Meltzer HY, Okayli G. Reduction of suicidality during clozapine treatment of neurolpetic-resistant schizophrenia: impact of risk-benefit assessment. Am. J. Psychiatry. 1995;152:183–190
  50. Montgomery SA, Roy D, Montgomery DB. The prevention of recurrent suicidal acts. Br. J. Clin. Pharmacol. 1983;15:183S–188S
  51. Morrison JR. Suicide in a psychiatric practice population. J. Clin. Psychiatry. 1982;43:348–352
  52. Müller-Oerlinghausen B, Ahrens B, Grof E, Grof P, Lenz G, Schou M, et al. The effect of long-term treatment on the mortality of patients with manic-depressive illness. Acta Psychiatr. Scand. 1992;86:218–222
  53. Müller-Oerlinghausen B, Berghöfer A. Antidepressants and suicidal risk. J. Clin. Psychiatry. 1999;60:94–99
  54. Murphy JM, Monson RR, Olivier DC, Sobol AM, Leighton AH. Affective disorders and mortality. Arch. Gen. Psychiatry. 1987;44:473–480
  55. Murphy JM, Monson RR, Olivier DC, Sobol AM, Pratt LA, Leighton AH. Mortality risk and psychiatric disorders. Results of a general physician survey. Soc. Psychiatry Psychiatr. Epidemiol. 1989;24:134–142
  56. Nilsson A. Mortality in recurrent mood disorders during periods on and off lithium. A complete population study in 362 patients. Pharmacopsychiatry. 1995;28:8–13
  57. Nilsson A. Lithium therapy and suicide risk. J. Clin. Psychiatry. 1999;60:85–88
  58. Rhimer Z, Pestality P. Bipolar II disorder and suicidal behavior. Psychiatr. Clin. North Am. 1999;22:ix–x
  59. Robins E, Murphy GE, Wilkinson RH, Gassner S, Kayes J. Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides. Am. J. Public Health. 1959;49:888–899
  60. Rorsman B. Mortality among psychiatric patients. Acta Psychiatr. Scand. 1974;50:354–375
  61. Rouillon F, Lejoyeux M, Filteau MJ. Unwanted effects of long-term treatment. In:  Montgomery SA,  Rouillon F editor. Long-term Treatment of Depression. Chichester, New York, Brisbane: John Wiley & Sons; 1992;p. 88–111
  62. Roy A. Features associated with suicide attempts in depression: a partial replication. J. Affect. Disord. 1993;27:35–38
  63. Rutz W, Von Knorring L, Walinder J. Frequency of suicide on Gotland after symptomatic postgraduate education of general practitioners. Acta Psychiatr. Scand. 1989;80:151–154
  64. Schwalb H, Schwalb M. Mortalität hospitalisierter psychiatrischer Patienten: Ergebnisse einer 10-Jahres-Studie. Fortschr. Neurol. Psychiatr. 1987;55:83–97
  65. Sharma R, Markar HR. Mortality in affective disorder. J. Affect. Disord. 1994;31:91–96
  66. Stallone F, Dunner DL, Ahearn J, Fieve RR. Statistical predictions of suicide in depressives. Compr. Psychiatry. 1980;21:381–387
  67. Surtees PG, Barkley C. Future imperfect: the long-term outcome of depression. Br. J. Psychiatry. 1994;164:327–341
  68. Thornicroft G, Sartorius N, Investigators OBOTC. The course and outcome of depression in different cultures: 10-year follow-up of the WHO Collaborative Study on the Assessment of Depressive Disorders. Psychol. Med. 1993;23:1023–1032
  69. Tsuang MT, Woolson RF. Excess mortality in schizophrenia and affective disorders. – Do suicides and accidental deaths solely account for this excess?. Arch. Gen. Psychiatry. 1978;35:1181–1185
  70. Walker AM, Lanza LL, Arellano F, Rothman KJ. Mortality in current and former users of clozapine. Epidemiology. 1997;8:671–677
  71. Weeke A. Causes of death in manic-depressives. In:  Schou M,  Strömgen E editor. Origin, Prevention and Treatment of Affective Disorders. London: Academic Press; 1979;p. 289–299
  72. Weeke A, Vaeth M. Excess mortality of bipolar and unipolar manic-depressive patients. J. Affect. Disord. 1986;11:227–234
  73. Winokur G, Tsuang MT. The Iowa 500. Suicide in mania, depression and schizophrenia. Am. J. Psychiatry. 1975;132:650–651
  74. Zheng D, Macera CA, Croft JB, Giles WH, Davis D, Scott WK. Major depression and all-cause mortality among white adults in the United States. Am. Epidemiol. 1997;7:213–218

PII: S0165-0327(01)00377-9

Journal of Affective Disorders
Volume 68, Issue 2 , Pages 167-181 , April 2002

Article Tools

* Image Usage & Resolution